Bristol Myers Squibb, one of the world’s leading biopharmaceutical companies will now establish a state-of-the-art facility in Hyderabad. This is to expand their global drug development and IT capabilities. The company will begin its operations in 2023. The announcement was made after Telangana IT Minister KT Rama Rao met Dr. Samit Hirawat MD, Executive Vice President, Chief Medical Officer, Global Drug Development at BMS.
He is in Hyderabad to participate in the 20th edition of the annual international convention BioAsia 2023. KTR took to Twitter to make the announcement. He tweeted, “Yet another Marquee Pharma major chooses #Telangana
Welcome Bristol Myers Squibb (BMS) to #Hyderabad as they set-up a state-of-the-art centre for global drug development & tech capabilities creating more than 1500 high quality jobs. Met @bmsnews team led by @SamitHirawat today.”
He added, “BMS is one of world’s largest and top 10 pharma company headquartered in NY. Telangana has emerged as the Hub of Lifesciences in Asia & with BMS’s addition to our long list of global giants strengthening our position further! #TelanganaLeadsLifesciences”
Yet another Marquee Pharma major chooses #Telangana😊
Welcome Bristol Myers Squibb (BMS) to #Hyderabad as they set-up a state-of-the-art centre for global drug development & tech capabilities creating more than 1500 high quality jobs. Met @bmsnews team led by @SamitHirawat today pic.twitter.com/q9bNEXaIPA
— KTR (@KTRBRS) February 23, 2023
